THERAKOS, INC.

Patent Owner

Watch Compare Add to Portfolio

Stats

Details

Patent Activity in the Last 10 Years

Technologies

Intl Class Technology Matters Rank in Class
 
  
 
A61N ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY 2105
 
  
 
A61M DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY 1153
 
  
 
B01L CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE 157
 
  
 
B04B CENTRIFUGES 126
 
  
 
F04B POSITIVE-DISPLACEMENT MACHINES FOR LIQUIDS; PUMPS 161
 
  
 
G01N INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES 1205
 
  
 
H01J ELECTRIC DISCHARGE TUBES OR DISCHARGE LAMPS 1127

Top Patents (by citation)

Upgrade to the Professional Level to View Top Patents for this Owner. Learn More

Recent Publications

  • No Recent Publications to Display

Recent Patents

Patent # Title Filing Date Issue Date Intl Class
8722422 Uninterrupted flow pump apparatus and methodMar 08, 12May 13, 14[B01L, F04B]
5569928 Photoactivation light arrayDec 14, 93Oct 29, 96[A61N]
5459322 Ultraviolet light chamberDec 14, 93Oct 17, 95[H01J, G01N]
5383847 Non-specific immune system enhancementJul 29, 92Jan 24, 95[A61M]
5330420 Hemolysis detectorJan 13, 92Jul 19, 94[A61N]
5308309 Securing system for centrifuge chamberDec 23, 92May 03, 94[B04B]

Expired/Abandoned/Withdrawn Patents

Patent # Title Status Filing Date Issue/Pub Date Intl Class
2014/0081,193 METHOD AND SYSTEM FOR ADJUSTING ROTATION SPEED OF AN EXTRACORPOREAL THERAPEUTIC DEVICEAbandonedSep 14, 12Mar 20, 14[A61M]
2010/0210,989 PROCESSING BLOODAbandonedDec 01, 09Aug 19, 10[A61M]
2009/0142,317 PROCESS FOR REDUCING EFFECTS OF GRAFT VERSUS HOST DISEASE USING EX VIVO EXPANDED CD4+CD25+ REGULATORY T CELLSAbandonedDec 01, 08Jun 04, 09[A61K]
2009/0142,318 METHOD TO EXPAND nTREG CELLS USING p70 S6 KINASE ANTAGONISTAbandonedFeb 03, 09Jun 04, 09[A61K, C12N]
2009/0142,319 METHOD TO EXPAND nTREG CELLS USING PI-3K ANTAGONISTAbandonedFeb 03, 09Jun 04, 09[A61K, C12N]
2009/0142,320 METHOD TO MINIMIZE IL-17 PRODUCTION DURING nTREG CELL EXPANSIONAbandonedFeb 03, 09Jun 04, 09[A61K, C12N, A61P]
2007/0264,663 Methods and reagents for detecting susceptibility to graft versus host disease or transplant related mortalityAbandonedMay 02, 07Nov 15, 07[C12Q]
2007/0098,686 Use of apoptotic cells ex vivo to generate regulatory T CellsAbandonedNov 02, 06May 03, 07[A61K]
2006/0252,674 Methods for pretreating a subject with extracorporeal photopheresisAbandonedOct 11, 05Nov 09, 06[A61K]
2006/0219,644 Control system for driving fluids through an extracorporeal blood circuitAbandonedJun 01, 06Oct 05, 06[C02F, B01D]
2006/0224,099 Control system for driving fluids through an extracorporeal blood circuitAbandonedJun 01, 06Oct 05, 06[A61M]
2006/0217,651 Control system for driving fluids through an extracorporeal blood circuitAbandonedJun 01, 06Sep 28, 06[A61M]
2005/0163,778 Extracorporeal photopheresis in combination with anti-TNF treatmentAbandonedDec 21, 04Jul 28, 05[A61K, A61N]
2003/0157,073 Methods for pretreating a subject with apoptotic cellsAbandonedNov 29, 02Aug 21, 03[A61K]
2003/0139,466 Methods for pretreating a subject with extracorporeal photopheresisAbandonedNov 29, 02Jul 24, 03[A61K]
5147289 Non-specific immune system enhancementExpiredMar 29, 90Sep 15, 92[A61M]
5036102 Method of treating autoimmune diseases comprising administration of psoralen dosage formsExpiredSep 14, 90Jul 30, 91[A61K]
4999375 Psoralen reagent compositions for extracorporeal treatment of bloodExpiredApr 11, 89Mar 12, 91[A61K]
4921473 Multicomponent fluid separation and irradiation systemExpiredFeb 02, 89May 01, 90[B04B]
4838852 Active specific immune suppressionExpiredMar 27, 87Jun 13, 89[A61M]

Top Inventors for This Owner

Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More

We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!

We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.